Serge Paul Eholié

2.7k total citations · 1 hit paper
39 papers, 1.6k citations indexed

About

Serge Paul Eholié is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Serge Paul Eholié has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 20 papers in Epidemiology and 9 papers in Virology. Recurrent topics in Serge Paul Eholié's work include HIV/AIDS Research and Interventions (15 papers), HIV Research and Treatment (9 papers) and HIV/AIDS drug development and treatment (9 papers). Serge Paul Eholié is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), HIV Research and Treatment (9 papers) and HIV/AIDS drug development and treatment (9 papers). Serge Paul Eholié collaborates with scholars based in Ivory Coast, France and United States. Serge Paul Eholié's co-authors include Pierre‐Yves Boëlle, Yazdan Yazdanpanah, Francesco Pinotti, Eugenio Valdano, Marius Gilbert, Vittoria Colizza, Giulia Pullano, Moritz U. G. Kraemer, Mathias Altmann and Bernardo Gutiérrez and has published in prestigious journals such as The Lancet, PLoS ONE and Hepatology.

In The Last Decade

Serge Paul Eholié

37 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study

2020 785 citations Marius Gilbert, Giulia Pullano et al. The Lancet profile →

Peers

Countries citing papers authored by Serge Paul Eholié

Since Specialization

Citations

This map shows the geographic impact of Serge Paul Eholié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Paul Eholié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Paul Eholié more than expected).

Fields of papers citing papers by Serge Paul Eholié

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serge Paul Eholié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Paul Eholié. The network helps show where Serge Paul Eholié may publish in the future.

Co-authorship network of co-authors of Serge Paul Eholié

This figure shows the co-authorship network connecting the top 25 collaborators of Serge Paul Eholié. A scholar is included among the top collaborators of Serge Paul Eholié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge Paul Eholié. Serge Paul Eholié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mortality, loss to follow-up and advanced HIV disease following virologic success in West African HIV-2 patients 2025 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Patrick Coffié, André Inwoley, Serge Paul Eholié, Didier Koumavi Ekouévi, Boris Tchounga	1
2	Targeted Pharmaceutical Analysis of Antibiotic Use by Risk Criteria in Patients Hospitalized in the Infectious and Tropical Diseases Department at Treichville Teaching Hospital (Abidjan, Côte d'Ivoire) 2023 ·Biomedical & Pharmacology Journal ·(unknown), (unknown), (unknown), (unknown), (unknown), Serge Paul Eholié	0
3	Incidence of HIV infection and associated factors among female sex workers in Côte d’Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assays 2022 ·PLoS ONE ·(unknown), (unknown), Mélanie Plazy, Patrick Coffié, (unknown), (unknown), Camille Anoma, Serge Paul Eholié, François Dabis, Joseph Larmarange, (unknown)	3
4	A community-based healthcare package combining testing and prevention tools, including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of hepatitis B virus, and sexual and reproductive health (SRH), targeting female sex workers (FSWs) in Côte d’Ivoire: the ANRS 12381 PRINCESSE project 2021 ·BMC Public Health ·(unknown), (unknown), Mélanie Plazy, (unknown), (unknown), (unknown), (unknown), Aude Jary, Patrick Coffié, Serge Paul Eholié, Joseph Larmarange, (unknown)	5
5	Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study breakdown → 2020 ·The Lancet ·Marius Gilbert, Giulia Pullano, Francesco Pinotti, Eugenio Valdano, Chiara Poletto, Pierre‐Yves Boëlle, Éric D’Ortenzio, Yazdan Yazdanpanah, Serge Paul Eholié, Mathias Altmann, Bernardo Gutiérrez, Moritz U. G. Kraemer, Vittoria Colizza	785
6	CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy 2018 ·AIDS Research and Human Retroviruses ·(unknown), Raoul Moh, (unknown), Delphine Gabillard, Xavier Anglaret, Serge Paul Eholié, Fabien Zoulim, Christine Danel, Karine Lacombe, Anders Boyd, (unknown)	3
7	Implementing preexposure prophylaxis among key populations 2018 ·AIDS ·Joseph Larmarange, (unknown), (unknown), (unknown), Mélanie Plazy, Christine Danel, Serge Paul Eholié	6
8	Prevalence of hepatitis C among HIV-1, HIV-2 and dually reactive patients: A multi-country cross-sectional survey in West Africa 2018 ·Journal of Public Health in Africa ·Didier Koumavi Ekouévi, Patrick Coffié, Boris Tchounga, (unknown), Antoine Jaquet, François Dabis, Serge Paul Eholié	2
9	Metabolic Disorders and Cardiovascular Risk in Treatment-Naive HIV-Infected Patients of Sub-Saharan Origin Starting Antiretrovirals: Impact of Westernized Lifestyle 2015 ·AIDS Research and Human Retroviruses ·Serge Paul Eholié, Karine Lacombe, (unknown), (unknown), (unknown), Pauline Campa, Olivier Bouchaud, E. Bissagnené, Pierre‐Marie Girard	15
10	Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration 2015 ·PLoS ONE ·Didier Koumavi Ekouévi, Véronique Avettand-Fènoël, Boris Tchounga, Patrick Coffié, Adrien Sawadogo, D.K. Minta, Albert Minga, Serge Paul Eholié, Jean‐Christophe Plantier, Florence Damond, François Dabis, Christine Rouzioux	15
11	Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis 2015 ·The Lancet HIV ·Nathan Ford, Zara Shubber, Graeme Meintjes, Beatriz Grinsztejn, Serge Paul Eholié, Edward J. Mills, Mary‐Ann Davies, Marco Vitória, Martina Penazzato, Sabin Nsanzimana, Lisa Frigati, D. O’Brien, Tom Ellman, Olawale Ajose, Alexandra Calmy, Meg Doherty	220
12	Cancer and HIV infection in referral hospitals from four West African countries 2015 ·Cancer Epidemiology ·Antoine Jaquet, Michael K. Odutola, Didier Koumavi Ekouévi, Aristophane Tanon, Emmanuel Oga, (unknown), Manhattan Charurat, Marcel Zannou, Serge Paul Eholié, Annie J. Sasco, E. Bissagnené, Clement Adebamowo, François Dabis	26
13	Identifying patients infected with hepatitis B virus in sub-Saharan Africa: potential for misclassification 2015 ·Diagnostic Microbiology and Infectious Disease ·Anders Boyd, Sarah Maylin, Raoul Moh, Delphine Gabillard, Hervé Menan, Nadia Mahjoub, Christine Danel, Xavier Anglaret, Serge Paul Eholié, Pierre‐Marie Girard, Fabien Zoulim, Constance Delaugerre, Karine Lacombe	2
14	Cryptoccocal meningitis and HIV in the era of HAART in Côte d’Ivoire 2012 ·Médecine et Maladies Infectieuses ·(unknown), E. Ehui, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Koffi Daho Adoubryn, Serge Paul Eholié, E. Bissagnené	16
15	The Spectrum of Cancers in West Africa: Associations with Human Immunodeficiency Virus 2012 ·PLoS ONE ·Aristophane Tanon, Antoine Jaquet, Didier Koumavi Ekouévi, (unknown), Innocent Adoubi, (unknown), (unknown), Marcel Zannou, Annie J. Sasco, Serge Paul Eholié, François Dabis, E. Bissagnené	39
16	Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire 2011 ·Malaria Journal ·(unknown), Patrick Coffié, (unknown), Caroline E. Sloan, (unknown), Serge Paul Eholié, Moussa Koné, François Dabis, Hervé Menan, Didier Koumavi Ekouévi	19
17	Alcohol use and non‐adherence to antiretroviral therapy in HIV‐infected patients in West Africa 2010 ·Addiction ·Antoine Jaquet, Didier Koumavi Ekouévi, Jules Bashi, (unknown), Eugène Messou, M Y Maïga, Hamar Alassane Traoré, Marcel Zannou, Calixte Guéhi, (unknown), Albert Minga, (unknown), Serge Paul Eholié, E. Bissagnené, Annie J. Sasco, François Dabis	52
18	HIV Type 1 Drug Resistance in Adults Receiving Highly Active Antiretroviral Therapy in Abidjan, Côte d'Ivoire 2009 ·AIDS Research and Human Retroviruses ·Debra L. Hanson, Christiane Adjé-Touré, (unknown), (unknown), Marie-Yolande Borget, (unknown), (unknown), Odette Tossou, Serge Paul Eholié, Auguste Kadio, Terence Chorba, John N. Nkengasong	14
19	Efavirenz versus indinavir chez les patients naïfs infectés par le VIH-1 à Abidjan (Côte d’Ivoire) 2008 ·Médecine et Maladies Infectieuses ·Aristophane Tanon, Serge Paul Eholié, (unknown), (unknown), (unknown), E. Ehui, (unknown), (unknown), (unknown), E. Bissagnené, (unknown)	5
20	Prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients who have rebound in viral load while receiving antiretroviral therapy in the UNAIDS–Drug Access Initiative in Abidjan, Côte dʼIvoire 2003 ·AIDS ·Christiane Adjé-Touré, (unknown), Debra L. Hanson, Thierry H. Roels, Kurt Hertogs, Brendan Larder, Fabien Diomandé, Martine Peeters, Serge Paul Eholié, Eve Lackritz, Terence Chorba, John N. Nkengasong	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact